A drug billed by Sanofi as a successor to its blockbuster inflammation and immunology blockbuster Dupixent is being prepared for phase 3 trials in asthma – even though it missed the mark in a midstage ...

GSK’s follow-up to its severe asthma therapy Nucala has shown its value in a pair of phase 3 trials, reducing exacerbations compared to placebo with dosing once every six months. The company says new ...

Jae Bratton has been writing about credit cards for NerdWallet since 2022. Her work has been published in The Washington Post, the Los Angeles Times, The Associated Press and the journal Studies in ...

State Farm and AARP top our list of the best final expense policies that help pay for your funeral and burial costs. Many, or all, of the products featured on this page are from our advertising ...

Get our weekly Home and Garden email for tips, and interior inspiration Air fryers are an indispensable kitchen appliance. While simple and inexpensive, these clever kitchen gadgets can cook ...

Sep. 28, 2025 — A groundbreaking international study has shown that a 2-in-1 budesonide-formoterol inhaler is far more effective than the standard salbutamol inhaler in children with mild asthma, ...